REVIEW

Recombinant adeno-associated viruses as a gene delivery vehicle for the use in molecular medicine

Blagov AV
About authors

Prospects of using oncolytic viruses in breast cancer therapy

Correspondence should be addressed: Alexander V. Blagov
Shchukinskaya, 5, k. 6, Moscow, 123182, Russia; ur.abmfpsc@vogalBA

About paper

Author contribution: Blagov AV — analysis of scientific literature, review authoring.

Received: 2021-11-30 Accepted: 2021-12-13 Published online: 2021-12-21
|
Table 1. Classification of BC subtypes by molecular oncogenes
Table 2. Current clinical trials of drugs based on oncolytic viruses and designed for BC treatment